News

GRP named a top economic development organization in the U.S.

RICHMOND, VA – The Greater Richmond Partnership (GRP) was named among the top 20 economic development organizations in the nation according to Site Selection magazine, a national publication targeting site location professionals and corporate executives making relocation decisions.

The 2022 Mac Conway Awards for Excellence in Economic Development, named in honor of Site Selection founding publisher H. McKinley ‘Mac’ Conway, are awarded annually to the top economic development organizations in the country determined by an index of corporate job creation and facility-related capital investment data calculated both cumulatively and per capita. This marks the first time since 2015 the publication has recognized GRP for outstanding work in its field. It was named a top organization four previous years plus two honorable mentions since its inception in 1994.

“In the last two years, we’ve done a lot of work to come out of the pandemic as a stronger and more focused region and organization. This includes benchmarking best of class regions and regional groups,” said Jennifer Wakefield, President and CEO of GRP. “We are thrilled to be recognized among the best economic development organizations in the country yet again. It’s a testament to our strong public-private partnership and the collaboration found throughout the region to bring jobs and investment to Greater Richmond.”

Earlier this year, Site Selection ranked Greater Richmond as the 3rd top metro for economic development projects per capita for 2021.

Read more here.

Recent News

11/21/2025

A new era of global growth: George Mason and Naugen launch international innovation accelerator

This month, a new Northern Virginia International Soft-Landing Accelerator (NISA) program, designed to help start-ups from around the globe find guidance, connections, and lab or office spaces at no cost, was launched to help develop new technologies in life sciences.Applications are now open for the first NISA cohort. Participants in the six-month program will have

11/20/2025

VIPC Signs MOU with AstraZeneca, Eli Lilly, Merck to Develop the Virginia Center for Advanced Pharmaceutical Manufacturing to Train Workforce of the Future

A Memorandum of Understanding (MOU) signed by the Virginia Innovation Partnership Corporation (VIPC) and AstraZeneca, Eli Lilly (Lilly), and Merck to develop the Virginia Center for Advanced Pharmaceutical Manufacturing (APM) was executed by Governor Glenn Youngkin at a statewide gathering with key leaders from Virginia’s life sciences ecosystem, higher-ed universities, and community colleges on October 31. This

11/11/2025

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the target loading concentrations for its two topical rapamycin delivery technologies have been successfully achieved. Specifically, a rapamycin loading concentration of 4% w/w has been achieved for Quoin’s proprietary topical